SCHEMBL21067477

SCHEMBL21067477

CC(C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2n[nH]c(-c3ccc(Cl)s3)n2)C1=O

nearest known ligand 0.76

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.76
F2 P00734 3/20 0.60
KLKB1 P03952 3/20 0.60
PLAT P00750 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067476 1.00 F10 (0.76) F10F2KLKB1PLAT
SCHEMBL4479236 0.84 F10 (1.00) F10F2KLKB1PLAT
SCHEMBL4702037 0.77 F10 (0.74) F10F2KLKB1PLAT
SCHEMBL4702674 0.77 F10 (0.74) F10F2KLKB1PLAT
SCHEMBL4702103 0.77 F10 (0.74) F10F2KLKB1PLAT
SCHEMBL5473483 0.76 F10 (1.00) F10
SCHEMBL4469108 0.76 F10 (0.80) F10
SCHEMBL4478893 0.76 F10 (1.00) F10
SCHEMBL23752209 0.76 F10 (1.00) F10F2KLKB1PLAT
Gw813893 SCHEMBL675587 0.76 F10 (1.00) F10F2KLKB1PLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed